Thyroid cancer under the scope of emerging technologies

Tarabichi, Maxime; Demetter, Pieter; Craciun, Ligia; Maenhaut, Carine; Detours, Vincent

doi:10.1016/j.mce.2021.111491

Cited by 12 publications

(8 citation statements)

References 194 publications

(220 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[70] In recent years, immunotherapy has been extensively used in cancer treatment including TC. [26,[71][72][73][74][75][76][77][78][79][80][81] In this study, papers on immunotherapy for TC were studied by using bibliometric method.…”

Section: Discussionmentioning

confidence: 99%

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Ding,

Jiao,

Piao

et al. 2023

Medicine

View full text Add to dashboard Cite

With the gradual development of immunotherapy for thyroid cancer, relevant research has increased. To better understand the current situation, development trend, evolution process, and research hotspots of this field, we conducted this comprehensive bibliometrics visual analysis. We retrieved papers published from 1980 to 2022 from Web of Science Core Collection on January 31, 2023. CiteSpace, Pajek, VOSviewer, R-Bibliometrix, and Scimago Graphics are the tools to perform the analysis. Analysis methods mainly include co-occurrence analysis and cluster analysis. Analysis objects are countries or regions, institutions, authors, journals, and keywords, etc. In terms of publication number, the recent decade has witnessed rapid growth. USA was the most prolific country and has the most influence in the cooperation team. Sweden took the lead in focus on this research field and lasted for 21 years. Garden State Cancer Center was released most papers (28). INSERM played a major role in institutional cooperation. Goldenberg DM published the most papers (48), with H-Index 25 and G-Index 43. Journal of Nuclear Medicine has the greatest papers published (41). The average impactor factor of the top 10 journals is 7.2058. The top keywords with high burst strength are: radioimmunotherapy (14.85), monoclonal antibody (13.78), non hodgkins lymphoma (12.54). The research field of immunotherapy for thyroid cancer will be further developed. This study provides a valuable reference for future research in the field.

show abstract

Section: Discussionmentioning

confidence: 99%

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Ding,

Jiao,

Piao

et al. 2023

Medicine

View full text Add to dashboard Cite

show abstract

“…A better understanding of thyroid cancer heterogeneity, enabled by new technological advances will undoubtedly impact thyroid cancer management, as reviewed by Tarabichi et al [ 124 ].…”

Section: Thyroid Carcinoma As An Example: Various Patterns Of Heterogeneitymentioning

confidence: 99%

Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications

Jacquemin

Antoine

Dom

et al. 2022

Cancers

Self Cite

View full text Add to dashboard Cite

Though heterogeneity of cancers is recognized and has been much discussed in recent years, the concept often remains overlooked in different routine examinations. Indeed, in clinical or biological articles, reviews, and textbooks, cancers and cancer cells are generally presented as evolving distinct entities rather than as an independent heterogeneous cooperative cell population with its self-oriented biology. There are, therefore, conceptual gaps which can mislead the interpretations/diagnostic and therapeutic approaches. In this short review, we wish to summarize and discuss various aspects of this dynamic evolving heterogeneity and its biological, pathological, clinical, diagnostic, and therapeutic implications, using thyroid carcinoma as an illustrative example.

show abstract

“…Analysis [10]- [17] Clinical Asessment [18]- [21] Detection and Identification [22]- [29] Diagnose [30]- [55] Classification and Characterization [56]- [64] Performance Improvement, Accuracy, and Diagnostic Evaluation (Optimization) [65]- [82] Treatment and Management [52], [39], [83]- [85] Prediction [86]- [89] Medical Robot [90] Telemedicine [91] The number of applied artificial intelligence for thyroid disorders is generally used to diagnose thyroid disorders (n = 26) and then followed to improve performance, accuracy, and diagnostic evaluation (n = 18). Generally, this application is based on CAD (computer-aided diagnosis) either in the form of ultrasound or other types of radiology and is also related to medical images.…”

Section: Applied Of Ai Referencementioning

confidence: 99%

Artificial Intelligence for Thyroid Disorders: A Systematic Review

Hakim

Satria

Arief

et al. 2021

SITech

View full text Add to dashboard Cite

The thyroid gland plays a very important role in hormonal regulation in the human body. If the thyroid gland has a disorder, it can affect the performance of body functions. The development of artificial intelligence technology today allows an expert such as a doctor to be helped by his work. One of the important roles of artificial intelligence is helping doctors, among others, to diagnose a patient to determine appropriate post-diagnosis care. The study aims to shed light on the role of artificial intelligence in the treatment of thyroid disorders.The thyroid gland plays a very important role in hormonal regulation in the human body. If the thyroid gland has a disorder, it can affect the performance of body functions. The development of artificial intelligence technology today allows an expert such as a doctor to be helped by his work. One of the important roles of artificial intelligence is helping doctors, among others, to diagnose a patient to determine appropriate post-diagnosis care. The study aims to shed light on the role of artificial intelligence in the treatment of thyroid disorders.

show abstract

Thyroid cancer under the scope of emerging technologies

Cited by 12 publications

References 194 publications

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Knowledge mapping of immunotherapy for thyroid cancer from 1980 to 2022: A review

Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications

Artificial Intelligence for Thyroid Disorders: A Systematic Review

Contact Info

Product

Resources

About